Hubert Huckel Net Worth & Insider Trades
Hubert Huckel - Director, Catalyst Pharmaceutical Partners, Inc
What is Hubert Huckel's Net Worth?
The current estimated net worth of Catalyst Pharmaceutical Partners, Inc's Director, Hubert Huckel, is estimated to be about $16.35M . Hubert Huckel owns about 1,304,134 units of Catalyst Pharmaceutical Partners, Inc common stock. In the last 6 years at Catalyst Pharmaceutical Partners, Inc, Hubert Huckel has sold an estimated value of $0 worth.
What is Hubert Huckel's Past Insider Trading?
Hubert Huckel's largest purchase order was 125,000 units , worth over $100K on May 29, 2012. In total, Hubert Huckel has made about 11 transactions over 6 years of their time at Catalyst Pharmaceutical Partners, Inc. Hubert Huckel usually trades in February, with the busiest year in 2008.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Hubert Huckel
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What is Hubert Huckel's' Mailing Address?
- Mailing address is C/o Titan Pharmaceuticals Inc 400 Oyster Point Blvd S San Francisco CA 94080 CA
Catalyst Pharmaceutical Partners, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Other Earnings Plans or Compensations
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Other Earnings Plans or Compensations
|
|---|---|---|---|---|---|---|---|---|
| Patrick J. McEnany | 2018 | $524,236 | $332,063 | $ | $3,461,504 | $3,461,504 | $ | $3,461,504 |
| Steven R. Miller, COO and CSO | 2018 | $427,441409,325 | $188,600 | $ | $1,655,195 | $1,655,195 | $11,000 | $1,655,195 |
| Gary Ingenito, CM&RO | 2018 | $399,373 | $194,810 | $ | $1,666,645 | $1,666,645 | $26,192 | $1,666,645 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1369568/000119312520188818/d932120ddef14a.htm
What are Catalyst Pharmaceutical Partners, Inc's Past Insider Trades?
Catalyst Pharmaceutical Partners, Inc's most recent insider trade came on May 17, 2023 by Patrick J McEnany who sold 26,151 units worth $345.98K . In the last 16 years, insiders at Catalyst Pharmaceutical Partners, Inc have sold an estimated value of $61.74M and bought an estimated value of $19.88M worth of shares. Insider trading is most common in December, with the busiest year in 2022. The most active traders at the company are Patrick J McEnany, President and CEO, Charles B. O'Keeffe, Director, and Philip H Coelho, Director .
CATALYST PHARMACEUTICALS, INC. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||